Flc Capital Advisors Novartis Ag Transaction History
Flc Capital Advisors
- $430 Million
- Q3 2024
A detailed history of Flc Capital Advisors transactions in Novartis Ag stock. As of the latest transaction made, Flc Capital Advisors holds 2,366 shares of NVS stock, worth $230,282. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,366
Previous 2,266
4.41%
Holding current value
$230,282
Previous $241,000
12.86%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$788 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$680 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$562 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $209B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...